Anti-PD-1 antibodies and uses thereof
US11905329B2 · kind B2 · utility
0Cited by
10References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2022 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Aug 10, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.